PeptidePedia The community reference

Contributions of AnaesthesiaAoife

User contributions·17 logged edits·page 1 of 1

Contributions by AnaesthesiaAoife, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,711 edits includes activity predating the current log.

  1. 10:50, 24 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 2,552 +2,552 N new article: supplier organisation, created after the notability discussion
  2. 14:00, 15 Jun 2026 (diff | hist) Talk:Aspiration risk under anaesthesia 748 +95 /* Ultrasound measures the thing itself */ reply
  3. 09:40, 1 Apr 2026 (diff | hist) Talk:Aspiration risk under anaesthesia 400 +173 /* Caution proportionate to severity, not evidence */ new section
  4. 09:07, 20 Mar 2026 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 split the gastrointestinal effects from the metabolic ones
  5. 21:05, 6 Feb 2026 (diff | hist) AmbioPharm 14,619 +1,173 add the incorporation year, attributed to the registry record
  6. 10:32, 20 Jan 2026 (diff | hist) Weight regain after discontinuation 4,670 ±0 clarify that the rodent finding has not been observed in humans
  7. 13:47, 9 Jan 2026 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 m close an unbalanced quotation mark
  8. 01:55, 19 Dec 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 add the contraindication with its rationale
  9. 21:36, 12 Nov 2025 (diff | hist) Melanotan II 4,649 ±0 add a hatnote separating this from the fragment of the same parent protein
  10. 18:05, 24 Oct 2025 (diff | hist) Chinese Peptide Company 15,293 ±0 m label the reception tally as weak, self-selected evidence at this point of use
  11. 11:05, 12 Jul 2025 (diff | hist) Exenatide 5,531 +1,059 clarify that the peptide backbone is acylated rather than PEGylated
  12. 07:27, 21 Jun 2025 (diff | hist) Tianjin Finder Chemical 8,980 +485 attribute the capability claim to the organisation's own material
  13. 21:07, 10 Jun 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,314 ±0 clarify that the rodent finding has not been observed in humans
  14. 03:22, 20 May 2025 (diff | hist) Methionine oxidation 3,850 ±0 m add the repeatability figure with the number of injections
  15. 15:19, 6 Mar 2025 (diff | hist) Haemoglobin A1c 3,366 ±0 m rm the diagnostic threshold — the article describes, it does not diagnose
  16. 18:31, 14 Oct 2024 (diff | hist) Weight regain after discontinuation 2,792 +978 state whether the figure is from a trial or from post-marketing reporting
  17. 07:05, 27 Sep 2024 (diff | hist) Weight regain after discontinuation 1,814 ±0 m unpipe a link that did not need piping